Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Joel Stephen Finkelstein, M.D.

Co-Author

This page shows the publications co-authored by Joel Finkelstein and Daniel Solomon.
Connection Strength

3.804
  1. Medication Use by Race and Ethnicity in Women Transitioning Through the Menopause: A Study of Women's Health Across the Nation Drug Epidemiology Study. J Womens Health (Larchmt). 2016 06; 25(6):599-605.
    View in: PubMed
    Score: 0.674
  2. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study. Osteoporos Int. 2016 Mar; 27(3):1181-1189.
    View in: PubMed
    Score: 0.652
  3. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Miner Res. 2015 Feb; 30(2):232-9.
    View in: PubMed
    Score: 0.622
  4. Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England. Osteoporos Int. 2003 Apr; 14(2):123-9.
    View in: PubMed
    Score: 0.273
  5. Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study. BMJ Open. 2021 05 11; 11(5):e045074.
    View in: PubMed
    Score: 0.240
  6. Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study. Arch Osteoporos. 2019 06 28; 14(1):73.
    View in: PubMed
    Score: 0.211
  7. Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results From the Study of Women's Health Across the Nation. J Pain. 2017 02; 18(2):178-187.
    View in: PubMed
    Score: 0.176
  8. Rates of bone loss among women initiating antidepressant medication use in midlife. J Clin Endocrinol Metab. 2013 Nov; 98(11):4355-63.
    View in: PubMed
    Score: 0.141
  9. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 2009 Jun; 60(6):1624-31.
    View in: PubMed
    Score: 0.105
  10. High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania. Int Q Community Health Educ. 2008-2009; 29(3):223-40.
    View in: PubMed
    Score: 0.095
  11. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007 Nov; 22(11):1808-15.
    View in: PubMed
    Score: 0.094
  12. A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int. 2006; 17(5):760-7.
    View in: PubMed
    Score: 0.083
  13. Compliance with osteoporosis medications. Arch Intern Med. 2005 Nov 14; 165(20):2414-9.
    View in: PubMed
    Score: 0.082
  14. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):219-26.
    View in: PubMed
    Score: 0.079
  15. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005 Feb; 80(2):194-202.
    View in: PubMed
    Score: 0.078
  16. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004 Jul; 19(7):783-90.
    View in: PubMed
    Score: 0.075
  17. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003 Oct 01; 115(5):398-400.
    View in: PubMed
    Score: 0.071
  18. Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the Nation. Clin Endocrinol (Oxf). 2019 07; 91(1):48-57.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.